MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Trinity Biotech plc Company Profile (NASDAQ:TRIB)

Consensus Ratings for Trinity Biotech plc (NASDAQ:TRIB) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $19.00 (67.40% upside)

Analysts' Ratings History for Trinity Biotech plc (NASDAQ:TRIB)
Show:
DateFirmActionRatingPrice TargetActions
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/5/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015Craig HallumDowngradeBuy -> Hold$24.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2015Raymond JamesInitiated CoverageOutperform$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/28/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha